Jenburkt Pharmaceuticals Ltd

524731·NSE·
₹0.00▲ +0.00 (+0.00%)
Market Cap455.50 Cr
PE Ratio14.30
Volume—
Day High - Low—
52W High-Low1073.90 - 1010.00

Jenburkt Pharmaceuticals Ltd (524731): company summary

Jenburkt Pharmaceuticals Ltd (524731) is a micro-cap Healthcare company valued at ₹456 crore operating in Pharmaceuticals on the NSE and BSE.

Jenburkt Pharmaceuticals Ltd (524731) is a micro-cap Healthcare company valued at ₹456 crore operating in Pharmaceuticals on the NSE and BSE.

Financial performance
Revenue has been growing steadily at 9.3% a year over three years; profit grew 11.6% a year, ahead of revenue — margins are expanding. Return on equity is 20.2%.
Valuation multiples
The stock trades at 14.3 times earnings, a discount to the Healthcare median of 32.5, 2.33 times book value. It yields 2.0%.

Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
7.4/10
Strong
Fair Value
Sign in to see
ROE
20.20%
Strong
P/E
14.30x
Cheap
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Strong

Price performance

52W₹1010
₹1074
DocStoX take

Supported by quality (8.3) and valuation (7.4), but weakest on risk (6.5). Scored on 4 of 5 measures.

DocStoX score

Medium confidence
7.4
/10
Strong
Quality
Excellent
ROE 20.2%
Valuation
Fair
P/E 14.3×
Growth
Steady
Revenue +10.4% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
No data
No technical indicators

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹456 Cr
52W High / Low
₹1074 / ₹1010
Dividend Yield
2.01%
Promoter Holding
46.62%
EPS (TTM)
₹72.64
Book Value
₹446.47

Key highlights

  • Low leverage — D/E 0.01
  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 27%
  • Small ₹456 cr company — thinner liquidity
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Jenburkt Pharmaceuticals Ltd’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Jenburkt Pharmaceuticals Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESMANIPAL HEALTH ENTERPRI LLUPIN LIMITED

Compare Jenburkt Pharmaceuticals Ltd with peers

Jenburkt Pharmaceuticals Ltd vs SUN PHARMACEUTICAL IND LJenburkt Pharmaceuticals Ltd vs DIVI S LABORATORIES LTDJenburkt Pharmaceuticals Ltd vs TORRENT PHARMACEUTICALS LJenburkt Pharmaceuticals Ltd vs APOLLO HOSPITALS ENTER. LJenburkt Pharmaceuticals Ltd vs ZYDUS LIFESCIENCES LTDJenburkt Pharmaceuticals Ltd vs CIPLA LTD

Related tools & concepts

Value Jenburkt Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing